|
| Professor Georg Birkmayer, M.D., Ph.D., developer of ENADA ® and ENADAlert® stabilized NADH, was the first to identify the importance of NADH in cellular development and energy transmissions for all bodily functions and organs. He founded Menuco Corporation in 1995 and is a world-renowned biochemical researcher and Medical Director of the Birkmayer Institute for Parkinson's Therapy, which has treated thousands of patients suffering from Parkinson's disease after having studied the biochemical connections between Parkinsons and NADH. |
|
